Developing novel anti-cancer therapies
| 04.-05. March | Sachs European Life Science CEO Forum, Zurich |
| 23.-25. March | BioSpring & RESI, Lisboa |
| 27.-28. April | BioVaria, Munich |
| 03.-05. May | Swiss Biotech Days, Basel |
| 04.-06. May | BioEquityEurope, Prague |
We look forward to networking with venture capital, business angels and industry leaders, discussing how RIANA’s STAT5 inhibitor program is paving the way for new treatments in oncology. If you’ll be there, we’d love to connect!
We look forward to networking with venture capital, business angels and industry leaders, discussing how RIANA’s STAT5 inhibitor program is paving the way for new treatments in oncology. If you’ll be there, we’d love to connect!
Dec 4, 2024 | London, UK
Meet our CBO, Christine Ruckenbauer, in person on December 4 or online afterwards, December 4-5.
The RESI (Redefining Early Stage Investments) event in London is the perfect platform for early-stage biotech startups like RIANA Therapeutics to connect with potential investors, explore funding opportunities, and showcase our innovative approach to advancing cancer therapies.
We look forward to networking with industry leaders and discussing how RIANA’s STAT5 inhibitor program is paving the way for new treatments in oncology. If you’ll be there, we’d love to connect!
RIANA Therapeutics 